Meta Analysis on Pregnancy and Perinatal Outcomes of Pregnant Women with COVID-19
Covid-19' was originated from the Wuhan, China, in December 2019, and it was also named as 2019-nCoV SARS-CoV-2. The corona virus 2 (SARS-CoV-2) is a newly discovered ribonucleic acid virus which is identified from the patients with unexplained pneumonia and severe in acute respiratory syndrome. This Meta-analysis aims to evaluate the effect on pregnancy, perinatal, and neonatal outcomes of pregnant women with Covid-19. This paper is mainly based on secondary data sources. Data has been collected from the reviews of international and national publications, such as journals, reports, articles, and e-resources published in April to November 2020. A formal extraction protocol workflow was used to measure Preferred Reporting Items for Systematic Review and Meta-Analysis Protocol (PRISMA-P). The findings show that 2099 newborns (including twins) were borned by 2093 pregnant women since the period of Covid-19. The result indicates that more than 74 percent of the pregnant women had given birth by cesarean section due to maternal Covid-19 complications and fetal distress. Most of the pregnant women have the following symptoms of Covid- 19, such as fever, cough, dyspnea, pneumonia, respiratory distress syndrome, premature delivery, etc; and neonates often have the following symptoms: respiratory distress pneumonia, bacterial pneumonia, neonatal death, and Covid-19 positive. This paper concludes that the pregnancy and perinatal outcome of pregnant women and neonates were varied, and their manifestation can range normal, mild, and severe.
© Molung Foundation